Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferhat Meziani

Showing results (21-30 of 160) with videos related to

Pageof 16
Sort By:
Annals of Intensive Care|May 24, 2013
Does vasopressor therapy have an indication in hemorrhagic shock?François Beloncle, Ferhat Meziani, Nicolas Lerolle, et al.
Annals of Intensive Care|January 17, 2025
Biomarkers of sepsis-induced coagulopathy: diagnostic insights and potential therapeutic implicationsAnaïs Curtiaud, Toshiaki Iba, Eduardo Angles-Cano, et al.
Intensive Care Medicine|May 22, 2020
Prothrombotic phenotype in COVID-19 severe patientsJulie Helms, François Severac, Hamid Merdji, et al.
Thrombosis Research|November 4, 2019
First visualization of circulating neutrophil extracellular traps using cell fluorescence during human septic shock-induced disseminated intravascular coagulationLaure Stiel, Caroline Mayeur-Rousse, Julie Helms, et al.
Journal of Critical Care|March 10, 2015
Doppler-based renal resistive index for prediction of renal dysfunction reversibility: A systematic review and meta-analysisSebastien Ninet, David Schnell, Antoine Dewitte, et al.
Pulmonary Circulation|December 29, 2017
Hemodynamic profile of pulmonary hypertension (PH) in ARDSGeorge Calcaianu, Mihaela Calcaianu, Anthony Gschwend, et al.
Annals of Intensive Care|May 6, 2023
Microcirculatory dysfunction in cardiogenic shockHamid Merdji, Bruno Levy, Christian Jung, et al.
American Journal of Hematology|January 7, 2010
Acquired factor V inhibitor in a context of sepsis and disseminated intravascular coagulationAnne Tessier-Marteau, Sabine Croquefer, Ferhat Meziani, et al.
Shock (Augusta, Ga.)|May 20, 2014
Dexamethasone and recombinant human activated protein C improve myocardial function and efficiency during experimental septic shockJeremie Lemarie, Alice Blet, Youcef Bouazza, et al.
Trends in Molecular Medicine|July 8, 2020
JAK-STAT Targeting Offers Novel Therapeutic Opportunities in SepsisRaphaël Clere-Jehl, Alexandre Mariotte, Ferhat Meziani, et al.
Pageof 16

Showing results (21-30 of 160) with videos related to

Sort By:
Pageof 16
Annals of Intensive Care|May 24, 2013
Does vasopressor therapy have an indication in hemorrhagic shock?François Beloncle, Ferhat Meziani, Nicolas Lerolle, et al.
Annals of Intensive Care|January 17, 2025
Biomarkers of sepsis-induced coagulopathy: diagnostic insights and potential therapeutic implicationsAnaïs Curtiaud, Toshiaki Iba, Eduardo Angles-Cano, et al.
Intensive Care Medicine|May 22, 2020
Prothrombotic phenotype in COVID-19 severe patientsJulie Helms, François Severac, Hamid Merdji, et al.
Thrombosis Research|November 4, 2019
First visualization of circulating neutrophil extracellular traps using cell fluorescence during human septic shock-induced disseminated intravascular coagulationLaure Stiel, Caroline Mayeur-Rousse, Julie Helms, et al.
Journal of Critical Care|March 10, 2015
Doppler-based renal resistive index for prediction of renal dysfunction reversibility: A systematic review and meta-analysisSebastien Ninet, David Schnell, Antoine Dewitte, et al.
Pulmonary Circulation|December 29, 2017
Hemodynamic profile of pulmonary hypertension (PH) in ARDSGeorge Calcaianu, Mihaela Calcaianu, Anthony Gschwend, et al.
Annals of Intensive Care|May 6, 2023
Microcirculatory dysfunction in cardiogenic shockHamid Merdji, Bruno Levy, Christian Jung, et al.
American Journal of Hematology|January 7, 2010
Acquired factor V inhibitor in a context of sepsis and disseminated intravascular coagulationAnne Tessier-Marteau, Sabine Croquefer, Ferhat Meziani, et al.
Shock (Augusta, Ga.)|May 20, 2014
Dexamethasone and recombinant human activated protein C improve myocardial function and efficiency during experimental septic shockJeremie Lemarie, Alice Blet, Youcef Bouazza, et al.
Trends in Molecular Medicine|July 8, 2020
JAK-STAT Targeting Offers Novel Therapeutic Opportunities in SepsisRaphaël Clere-Jehl, Alexandre Mariotte, Ferhat Meziani, et al.
Pageof 16